STTK:NASDAQShattuck Labs, Inc. Analysis
Data as of 2026-05-03 - not real-time
$6.99
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Shattuck Labs, Inc. is trading in a bullish technical environment, with price above its 20‑day moving average and a clear upward trend despite a bearish MACD histogram and a neutral RSI near 50. The stock sits near its identified support at $6.36 and faces resistance around $8.33, while market sentiment is at an "Extreme Greed" level, indicating strong short‑term buying pressure.
Fundamentally, the company reports negative earnings, high cash burn, and a price‑to‑sales ratio exceeding 500, suggesting the current valuation is stretched relative to its financial performance. However, recent coverage initiation by Cantor Fitzgerald and upcoming Phase I data for SL‑325 in Q2 2026 provide a catalyst that could justify the consensus "strong buy" rating and the median price target of $12.
Fundamentally, the company reports negative earnings, high cash burn, and a price‑to‑sales ratio exceeding 500, suggesting the current valuation is stretched relative to its financial performance. However, recent coverage initiation by Cantor Fitzgerald and upcoming Phase I data for SL‑325 in Q2 2026 provide a catalyst that could justify the consensus "strong buy" rating and the median price target of $12.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with limited upside before hitting resistance
- Bearish MACD histogram indicating potential short‑term pullback
- Upcoming Phase I data could cause volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst initiation and strong consensus "strong buy" recommendation
- Target upside of ~70% to the median $12 price target
- Bullish trend direction and extreme‑greed market sentiment
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Pipeline potential with DR3‑targeted antibodies and oncology program
- Long‑term growth narrative in the biotech sector despite current cash burn
- Substantial cash reserves relative to modest debt providing runway
Key Metrics & Analysis
Financial Health
P/E Ratio-14.6
ROE-60.25%
ROA-35.31%
Debt/Equity2.94
P/B Ratio5.4
Op. Cash Flow$-39882000
Free Cash Flow$-21513876
Industry P/E25.6
Technical Analysis
TrendBullish
RSI50.4
Support$6.36
Resistance$8.33
MA 20$7.29
MA 50$6.21
MA 200$3.35
MACDBearish
VolumeStable
Fear & Greed Index91.09
Valuation
Target Price$12.00
Upside/Downside71.67%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.60
Volatility55.18%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.